Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-20 08:00 am Purchase |
2023-07-10 | 13G | Surface Oncology, Inc. SURF |
ADAR1 Partners LP | 3,183,242 5.240% |
3,183,242 (New Position) |
Filing History |
| 2023-02-13 2:08 pm Sale |
2022-12-31 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 3,924,713 6.500% |
-728,287 (-15.65%) |
Filing History |
| 2023-02-10 2:08 pm Sale |
2022-12-31 | 13G | Surface Oncology, Inc. SURF |
ARK Investment Management LLC | 5,567,224 9.200% |
-756,309 (-11.96%) |
Filing History |
| 2023-01-31 08:57 am Unchanged |
2022-12-31 | 13G | Surface Oncology, Inc. SURF |
Atlas Venture Fund IX L.P. | 2,945,453 4.870% |
0 (Unchanged) |
Filing History |
| 2022-08-09 09:46 am Purchase |
2022-07-31 | 13G | Surface Oncology, Inc. SURF |
ARK Investment Management LLC | 6,323,533 11.580% |
997,406 (+18.73%) |
Filing History |
| 2022-05-09 3:12 pm Sale |
2022-04-30 | 13G | Surface Oncology, Inc. SURF |
BLACKROCK INC BLK |
2,502,271 4.600% |
-60,414 (-2.36%) |
Filing History |
| 2022-03-14 3:55 pm Purchase |
2022-03-11 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 4,653,000 9.900% |
4,604,442 (+9482.36%) |
Filing History |
| 2022-02-10 4:26 pm Purchase |
2021-12-31 | 13G | Surface Oncology, Inc. SURF |
LILLY ELI & CO LLY |
1,593,997 3.500% |
1,593,997 (New Position) |
Filing History |
| 2022-02-09 3:04 pm Purchase |
2021-12-31 | 13G | Surface Oncology, Inc. SURF |
ARK Investment Management LLC | 5,326,127 11.540% |
849,707 (+18.98%) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Surface Oncology, Inc. SURF |
FMR CORP | 1,729,801 3.749% |
-318,520 (-15.55%) |
Filing History |
| 2022-02-04 4:26 pm Purchase |
2021-12-31 | 13G | Surface Oncology, Inc. SURF |
BLACKROCK INC BLK |
2,562,685 5.600% |
2,562,685 (New Position) |
Filing History |
| 2022-01-25 11:30 am Unchanged |
2021-12-31 | 13G | Surface Oncology, Inc. SURF |
Atlas Venture Fund IX L.P. | 2,945,453 6.380% |
0 (Unchanged) |
Filing History |
| 2021-07-09 12:05 pm Purchase |
2021-06-30 | 13G | Surface Oncology, Inc. SURF |
ARK Investment Management LLC | 4,476,420 10.310% |
1,934,029 (+76.07%) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
ARK Investment Management LLC | 2,542,391 6.250% |
2,542,391 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Venrock Healthcare Capital Partners II, L.P. | 1,442,895 3.500% |
-2,435,000 (-62.79%) |
Filing History |
| 2021-02-16 12:16 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 48,558 0.100% |
-4,985,303 (-99.04%) |
Filing History |
| 2021-02-12 5:08 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Lilly Ventures Fund I LLC | 3,447,817 8.500% |
-36,801 (-1.06%) |
Filing History |
| 2021-02-12 1:28 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
New Enterprise Associates 14, L.P. | 0 0.000% |
-3,312,877 (Position Closed) |
Filing History |
| 2021-02-11 5:10 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,125,650 (Position Closed) |
Filing History |
| 2021-02-10 06:33 am Purchase |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
LV Management Group LLC | 56,173 0.100% |
56,173 (New Position) |
Filing History |